nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—renal system—cervical cancer	0.0206	0.0595	CbGeAlD
Isoprenaline—PIK3R2—female reproductive system—cervical cancer	0.0165	0.0477	CbGeAlD
Isoprenaline—PIK3R2—female gonad—cervical cancer	0.015	0.0434	CbGeAlD
Isoprenaline—PIK3R3—decidua—cervical cancer	0.0143	0.0411	CbGeAlD
Isoprenaline—PIK3R3—endometrium—cervical cancer	0.0135	0.039	CbGeAlD
Isoprenaline—PIK3R1—uterine cervix—cervical cancer	0.0128	0.0369	CbGeAlD
Isoprenaline—PIK3R3—uterus—cervical cancer	0.0125	0.036	CbGeAlD
Isoprenaline—PIK3R1—decidua—cervical cancer	0.0122	0.0351	CbGeAlD
Isoprenaline—PIK3R1—endometrium—cervical cancer	0.0116	0.0334	CbGeAlD
Isoprenaline—PIK3R3—female reproductive system—cervical cancer	0.0112	0.0323	CbGeAlD
Isoprenaline—PIK3R1—mammalian vulva—cervical cancer	0.0112	0.0323	CbGeAlD
Isoprenaline—PIK3R1—uterus—cervical cancer	0.0107	0.0307	CbGeAlD
Isoprenaline—PIK3R3—female gonad—cervical cancer	0.0102	0.0294	CbGeAlD
Isoprenaline—PIK3R3—vagina—cervical cancer	0.0101	0.0293	CbGeAlD
Isoprenaline—MAPK1—epithelium—cervical cancer	0.00879	0.0254	CbGeAlD
Isoprenaline—MAPK1—uterine cervix—cervical cancer	0.00871	0.0251	CbGeAlD
Isoprenaline—PIK3R1—female gonad—cervical cancer	0.00871	0.0251	CbGeAlD
Isoprenaline—PIK3R1—vagina—cervical cancer	0.00866	0.025	CbGeAlD
Isoprenaline—MAPK1—decidua—cervical cancer	0.0083	0.024	CbGeAlD
Isoprenaline—ADRBK1—renal system—cervical cancer	0.00827	0.0239	CbGeAlD
Isoprenaline—MAPK1—renal system—cervical cancer	0.00815	0.0235	CbGeAlD
Isoprenaline—MAPK1—mammalian vulva—cervical cancer	0.00762	0.022	CbGeAlD
Isoprenaline—MAPK1—uterus—cervical cancer	0.00726	0.021	CbGeAlD
Isoprenaline—ADRB3—female reproductive system—cervical cancer	0.00678	0.0196	CbGeAlD
Isoprenaline—ADRBK1—female reproductive system—cervical cancer	0.00662	0.0191	CbGeAlD
Isoprenaline—PIK3R3—lymph node—cervical cancer	0.00656	0.0189	CbGeAlD
Isoprenaline—MAPK1—female reproductive system—cervical cancer	0.00653	0.0188	CbGeAlD
Isoprenaline—ADRB3—female gonad—cervical cancer	0.00617	0.0178	CbGeAlD
Isoprenaline—ADRBK1—female gonad—cervical cancer	0.00603	0.0174	CbGeAlD
Isoprenaline—ADRBK1—vagina—cervical cancer	0.00599	0.0173	CbGeAlD
Isoprenaline—MAPK1—female gonad—cervical cancer	0.00594	0.0171	CbGeAlD
Isoprenaline—MAPK1—vagina—cervical cancer	0.0059	0.017	CbGeAlD
Isoprenaline—PIK3R1—lymph node—cervical cancer	0.0056	0.0162	CbGeAlD
Isoprenaline—ADRBK1—lymph node—cervical cancer	0.00387	0.0112	CbGeAlD
Isoprenaline—MAPK1—lymph node—cervical cancer	0.00382	0.011	CbGeAlD
Isoprenaline—ADRB1—female reproductive system—cervical cancer	0.00277	0.008	CbGeAlD
Isoprenaline—CYP1A1—epithelium—cervical cancer	0.00241	0.00694	CbGeAlD
Isoprenaline—CYP1A1—uterine cervix—cervical cancer	0.00239	0.00688	CbGeAlD
Isoprenaline—CYP1A1—renal system—cervical cancer	0.00223	0.00644	CbGeAlD
Isoprenaline—CYP1A1—mammalian vulva—cervical cancer	0.00209	0.00602	CbGeAlD
Isoprenaline—CYP1A1—uterus—cervical cancer	0.00199	0.00574	CbGeAlD
Isoprenaline—CYP1A1—female reproductive system—cervical cancer	0.00179	0.00516	CbGeAlD
Isoprenaline—CYP1A1—female gonad—cervical cancer	0.00163	0.00469	CbGeAlD
Isoprenaline—CYP1A1—vagina—cervical cancer	0.00162	0.00466	CbGeAlD
Isoprenaline—CYP1A1—lymph node—cervical cancer	0.00105	0.00302	CbGeAlD
Isoprenaline—MAPK1—Signaling by NGF—MTOR—cervical cancer	0.000133	0.000203	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—MTOR—cervical cancer	0.000132	0.000202	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—FGFR3—cervical cancer	0.000132	0.000202	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—CD4—cervical cancer	0.000132	0.000202	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HES1—cervical cancer	0.000131	0.0002	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.00013	0.0002	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—EGFR—cervical cancer	0.000129	0.000198	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—WNT5A—cervical cancer	0.000129	0.000197	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000129	0.000197	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HES1—cervical cancer	0.000129	0.000197	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—WNT5A—cervical cancer	0.000126	0.000193	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TAAR6—cervical cancer	0.000126	0.000193	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—WNT5A—cervical cancer	0.000126	0.000192	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—WNT5A—cervical cancer	0.000125	0.000191	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—NOTCH1—cervical cancer	0.000124	0.000189	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—WNT5A—cervical cancer	0.000124	0.000189	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TAAR6—cervical cancer	0.000123	0.000189	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TERT—cervical cancer	0.000123	0.000188	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—CASP3—cervical cancer	0.000122	0.000187	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CASP8—cervical cancer	0.000122	0.000187	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—CTNNB1—cervical cancer	0.000122	0.000186	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000121	0.000185	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—EGFR—cervical cancer	0.000121	0.000185	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-DQB1—cervical cancer	0.000121	0.000185	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—MTHFR—cervical cancer	0.000121	0.000185	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—CTNNB1—cervical cancer	0.00012	0.000184	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TP53—cervical cancer	0.00012	0.000183	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000117	0.000179	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—EGFR—cervical cancer	0.000116	0.000178	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—WNT2—cervical cancer	0.000116	0.000177	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MTHFR—cervical cancer	0.000115	0.000176	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HES1—cervical cancer	0.000115	0.000176	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TERT—cervical cancer	0.000114	0.000175	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—NOTCH1—cervical cancer	0.000114	0.000175	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—FGFR3—cervical cancer	0.000114	0.000174	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MTHFR—cervical cancer	0.000113	0.000173	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TP53—cervical cancer	0.000113	0.000173	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TERT—cervical cancer	0.000113	0.000173	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD8A—cervical cancer	0.000113	0.000172	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—FGFR3—cervical cancer	0.000112	0.000171	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOTCH2—cervical cancer	0.000112	0.000171	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—MTOR—cervical cancer	0.000111	0.00017	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—CD4—cervical cancer	0.000111	0.00017	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—cervical cancer	0.00011	0.000169	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOTCH2—cervical cancer	0.00011	0.000168	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—STAT3—cervical cancer	0.000109	0.000167	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000108	0.000165	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—FGFR3—cervical cancer	0.000108	0.000165	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—MTOR—cervical cancer	0.000107	0.000164	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CD4—cervical cancer	0.000107	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HES1—cervical cancer	0.000106	0.000162	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-DPB1—cervical cancer	0.000105	0.000161	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—FGFR3—cervical cancer	0.000105	0.000161	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000104	0.00016	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—FGFR3—cervical cancer	0.000103	0.000158	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—STAT3—cervical cancer	0.000103	0.000157	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKAP13—cervical cancer	0.000101	0.000155	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TERT—cervical cancer	0.000101	0.000154	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—MTOR—cervical cancer	0.0001	0.000154	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD4—cervical cancer	0.0001	0.000153	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—CTNNB1—cervical cancer	9.87e-05	0.000151	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NOTCH1—cervical cancer	9.86e-05	0.000151	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—WNT2—cervical cancer	9.84e-05	0.000151	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CASP8—cervical cancer	9.73e-05	0.000149	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NOTCH1—cervical cancer	9.71e-05	0.000149	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—EGFR—cervical cancer	9.65e-05	0.000148	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—WNT2—cervical cancer	9.63e-05	0.000147	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—MTHFR—cervical cancer	9.61e-05	0.000147	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CASP8—cervical cancer	9.58e-05	0.000147	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—EGFR—cervical cancer	9.51e-05	0.000145	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—EGFR—cervical cancer	9.32e-05	0.000143	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MTHFR—cervical cancer	9.3e-05	0.000142	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TERT—cervical cancer	9.27e-05	0.000142	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—MTOR—cervical cancer	9.27e-05	0.000142	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—EGFR—cervical cancer	9.27e-05	0.000142	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—CD4—cervical cancer	9.25e-05	0.000142	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—FGFR3—cervical cancer	9.23e-05	0.000141	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—FGFR3—cervical cancer	9.22e-05	0.000141	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CASP8—cervical cancer	9.2e-05	0.000141	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HES1—cervical cancer	9.15e-05	0.00014	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOTCH2—cervical cancer	9.04e-05	0.000138	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HES1—cervical cancer	9.01e-05	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—cervical cancer	9e-05	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CTNNB1—cervical cancer	8.9e-05	0.000136	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOTCH2—cervical cancer	8.82e-05	0.000135	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—WNT5A—cervical cancer	8.75e-05	0.000134	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NOTCH1—cervical cancer	8.66e-05	0.000133	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKAP13—cervical cancer	8.64e-05	0.000132	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—FGFR3—cervical cancer	8.51e-05	0.00013	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKAP13—cervical cancer	8.45e-05	0.000129	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—EGFR—cervical cancer	8.43e-05	0.000129	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—cervical cancer	8.34e-05	0.000128	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—CTNNB1—cervical cancer	8.22e-05	0.000126	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-DQB1—cervical cancer	8.2e-05	0.000126	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TERT—cervical cancer	8.01e-05	0.000123	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—MTOR—cervical cancer	8e-05	0.000122	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOTCH1—cervical cancer	7.99e-05	0.000122	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD4—cervical cancer	7.99e-05	0.000122	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TERT—cervical cancer	7.89e-05	0.000121	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—MTOR—cervical cancer	7.88e-05	0.000121	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CASP8—cervical cancer	7.88e-05	0.000121	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD4—cervical cancer	7.87e-05	0.00012	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—EGFR—cervical cancer	7.82e-05	0.00012	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—MTHFR—cervical cancer	7.79e-05	0.000119	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—STAT3—cervical cancer	7.76e-05	0.000119	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—EGFR—cervical cancer	7.72e-05	0.000118	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD8A—cervical cancer	7.66e-05	0.000117	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—CTNNB1—cervical cancer	7.6e-05	0.000116	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—MTOR—cervical cancer	7.57e-05	0.000116	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CD4—cervical cancer	7.55e-05	0.000116	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—EGFR—cervical cancer	7.51e-05	0.000115	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—WNT5A—cervical cancer	7.46e-05	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HES1—cervical cancer	7.41e-05	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MTOR—cervical cancer	7.39e-05	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CD4—cervical cancer	7.38e-05	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FGFR3—cervical cancer	7.35e-05	0.000113	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—WNT5A—cervical cancer	7.3e-05	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—cervical cancer	7.29e-05	0.000112	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MTOR—cervical cancer	7.28e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CD4—cervical cancer	7.26e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FGFR3—cervical cancer	7.24e-05	0.000111	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CA9—cervical cancer	7.24e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HES1—cervical cancer	7.23e-05	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HES1—cervical cancer	7.19e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—STAT3—cervical cancer	7.16e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CTNNB1—cervical cancer	7.1e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—EGFR—cervical cancer	7.05e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CTNNB1—cervical cancer	6.99e-05	0.000107	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOTCH1—cervical cancer	6.91e-05	0.000106	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOTCH1—cervical cancer	6.8e-05	0.000104	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CTNNB1—cervical cancer	6.71e-05	0.000103	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—STAT3—cervical cancer	6.62e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CTNNB1—cervical cancer	6.55e-05	0.0001	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—EGFR—cervical cancer	6.51e-05	9.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TERT—cervical cancer	6.49e-05	9.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MTOR—cervical cancer	6.49e-05	9.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MTOR—cervical cancer	6.48e-05	9.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD4—cervical cancer	6.47e-05	9.9e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CTNNB1—cervical cancer	6.45e-05	9.87e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TERT—cervical cancer	6.34e-05	9.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTHFR—cervical cancer	6.32e-05	9.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TERT—cervical cancer	6.3e-05	9.65e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FGFR3—cervical cancer	6.27e-05	9.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—STAT3—cervical cancer	6.18e-05	9.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—EGFR—cervical cancer	6.15e-05	9.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOTCH2—cervical cancer	6.14e-05	9.4e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—STAT3—cervical cancer	6.09e-05	9.32e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—EGFR—cervical cancer	6.06e-05	9.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—EGFR—cervical cancer	6.02e-05	9.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MTOR—cervical cancer	5.99e-05	9.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD4—cervical cancer	5.98e-05	9.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CASP3—cervical cancer	5.97e-05	9.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FGFR3—cervical cancer	5.96e-05	9.12e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FGFR3—cervical cancer	5.82e-05	8.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—FGFR3—cervical cancer	5.78e-05	8.85e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CTNNB1—cervical cancer	5.75e-05	8.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CTNNB1—cervical cancer	5.75e-05	8.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—STAT3—cervical cancer	5.71e-05	8.74e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—STAT3—cervical cancer	5.62e-05	8.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EGFR—cervical cancer	5.62e-05	8.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOTCH1—cervical cancer	5.59e-05	8.56e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EGFR—cervical cancer	5.54e-05	8.47e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOTCH1—cervical cancer	5.46e-05	8.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOTCH1—cervical cancer	5.43e-05	8.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CASP8—cervical cancer	5.36e-05	8.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EGFR—cervical cancer	5.32e-05	8.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CTNNB1—cervical cancer	5.31e-05	8.12e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	5.24e-05	8.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EGFR—cervical cancer	5.19e-05	7.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MTOR—cervical cancer	5.17e-05	7.92e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOTCH2—cervical cancer	5.12e-05	7.84e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EGFR—cervical cancer	5.11e-05	7.82e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MTOR—cervical cancer	5.1e-05	7.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HES1—cervical cancer	5.04e-05	7.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—STAT3—cervical cancer	5.02e-05	7.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—STAT3—cervical cancer	5.01e-05	7.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—EGFR—cervical cancer	4.98e-05	7.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—cervical cancer	4.96e-05	7.59e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—EGFR—cervical cancer	4.87e-05	7.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CASP3—cervical cancer	4.76e-05	7.28e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP3—cervical cancer	4.69e-05	7.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—cervical cancer	4.68e-05	7.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—STAT3—cervical cancer	4.63e-05	7.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CTNNB1—cervical cancer	4.59e-05	7.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EGFR—cervical cancer	4.56e-05	6.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EGFR—cervical cancer	4.55e-05	6.97e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CTNNB1—cervical cancer	4.52e-05	6.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TERT—cervical cancer	4.41e-05	6.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MTOR—cervical cancer	4.41e-05	6.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—cervical cancer	4.4e-05	6.73e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HES1—cervical cancer	4.29e-05	6.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EGFR—cervical cancer	4.2e-05	6.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HES1—cervical cancer	4.2e-05	6.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MTOR—cervical cancer	4.19e-05	6.42e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MTOR—cervical cancer	4.09e-05	6.26e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTOR—cervical cancer	4.07e-05	6.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—cervical cancer	4.06e-05	6.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FGFR3—cervical cancer	4.05e-05	6.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—STAT3—cervical cancer	4e-05	6.12e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—STAT3—cervical cancer	3.94e-05	6.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CTNNB1—cervical cancer	3.91e-05	5.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—cervical cancer	3.86e-05	5.9e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—cervical cancer	3.83e-05	5.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOTCH1—cervical cancer	3.8e-05	5.82e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—cervical cancer	3.76e-05	5.76e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TERT—cervical cancer	3.76e-05	5.76e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CTNNB1—cervical cancer	3.72e-05	5.69e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TERT—cervical cancer	3.68e-05	5.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EGFR—cervical cancer	3.63e-05	5.56e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CTNNB1—cervical cancer	3.63e-05	5.55e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CTNNB1—cervical cancer	3.61e-05	5.52e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EGFR—cervical cancer	3.58e-05	5.48e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGFR3—cervical cancer	3.45e-05	5.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—cervical cancer	3.41e-05	5.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EGFR—cervical cancer	3.39e-05	5.19e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGFR3—cervical cancer	3.38e-05	5.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	3.24e-05	4.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—cervical cancer	3.24e-05	4.96e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOTCH1—cervical cancer	3.17e-05	4.85e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—cervical cancer	3.16e-05	4.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—cervical cancer	3.14e-05	4.81e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EGFR—cervical cancer	3.1e-05	4.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—cervical cancer	3.05e-05	4.67e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—cervical cancer	3.01e-05	4.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EGFR—cervical cancer	2.94e-05	4.51e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—cervical cancer	2.94e-05	4.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EGFR—cervical cancer	2.89e-05	4.42e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EGFR—cervical cancer	2.87e-05	4.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EGFR—cervical cancer	2.86e-05	4.37e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MTOR—cervical cancer	2.85e-05	4.36e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EGFR—cervical cancer	2.82e-05	4.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—cervical cancer	2.62e-05	4.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CTNNB1—cervical cancer	2.53e-05	3.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—cervical cancer	2.47e-05	3.78e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MTOR—cervical cancer	2.43e-05	3.72e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—cervical cancer	2.41e-05	3.69e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MTOR—cervical cancer	2.38e-05	3.64e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—cervical cancer	2.23e-05	3.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—cervical cancer	2.2e-05	3.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—cervical cancer	2.19e-05	3.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	2.15e-05	3.3e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CTNNB1—cervical cancer	2.11e-05	3.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EGFR—cervical cancer	2e-05	3.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—cervical cancer	1.88e-05	2.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—cervical cancer	1.84e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGFR—cervical cancer	1.71e-05	2.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—cervical cancer	1.68e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGFR—cervical cancer	1.67e-05	2.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—cervical cancer	1.43e-05	2.19e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—cervical cancer	1.4e-05	2.14e-05	CbGpPWpGaD
